Common respiratory infections may have protected children from COVID-19

Analysing nasal swabs taken during the pandemic, researchers at Yale School of Medicine suggest that the frequent presence of other viruses and bacteria may have helped to protect children from the worst effects of COVID-19 by boosting their immune systems.

New cases slowing in Escherichia coli outbreak

The UK Health Security Agency (UKHSA), is continuing to work with partners to investigate the recent Shiga toxin-producing Escherichia coli (STEC) outbreak. It has confirmed further cases, including two deaths, but numbers of new cases are now decreasing.

Diagnostic stewardship approach to C. difficile reduces unnecessary testing

A new study describes the outcome of a new approach to testing for Clostridioides difficile, guided by the principles of diagnostic stewardship and how it highlights the benefits of a clearly defined, evidence-based test-ordering process.

Bio-Rad updates Celselect Slides to enhance cancer research

Bio-Rad Laboratories has launched Celselect Slides 2.0 to enhance rare cell and circulating tumour cell (CTC) capture. Compatible with Bio-Rad’s Genesis Cell Isolation System, the latest version of Celselect Slides enables the processing of greater volumes of liquid biopsy samples and offers the ability to capture and recover a greater number of CTCs for enumeration or use in downstream applications.

New US alliance to help laboratories accelerate adoption of digital pathology

Proscia has established a new partner alliance – named Proscia Ready - to help laboratories grow their use of digital pathology through an increasingly comprehensive approach.

Synnovis cyberattack: patient data stolen and posted online

London-based pathology services partnership Synnovis has issued a further update following the recent cyberattack, confirming that patient information published online was stolen from its systems.

Bio-Rad extends range of anti-biotherapeutic antibodies

Bio-Rad Laboratories has launched four new anti-idiotypic antibodies to the following drugs: atezolizumab (Tecentriq), avelumab (Bavencio), obinutuzumab (Gazyvaro), and ocrelizumab (Ocrevus), extending its range of anti-biotherapeutic antibodies. The company also introduced its anti-monomethyl auristatin E (MMAE) biotherapeutic antibody range for bioanalysis.

Free webinar - current and future trends in TDM for IBD management

BIOHIT HealthCare is excited to announce an upcoming webinar, 'Current and future trends in inflammatory bowel disease (IBD) therapeutic drug monitoring (TDM)', which will take place on 3 July at 12:30-1:30pm BST.

Simple test for influenza could improve diagnosis and surveillance

A low-cost CRISPR-based paper-strip test distinguishes between influenza types and can be reprogrammed to recognise different viruses including H5N1 bird influenza. A recently published paper describes the development of the new test that could allow more patients to find out which type of influenza they have and get the right treatment.

2024 RCPath Achievement Awards

The Royal College of Pathologists (RCPath) has announced the winners of its Achievement Awards. Six RCPath Achievement Awards were presented this year, four 'Team' awards and two awards for in the new category of 'Sustainability'.

Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time – Experiences and Opportunities

Following five popular meetings, Cardiac Marker Dialogues is pleased to be back with an exciting programme for a sixth meeting in Glasgow in September 2024.

New analytical units for cobas pro integrated solutions

Roche has launched new analytical units, cobas c 703 and cobas ISE neo, for the cobas pro integrated solutions, in countries accepting the CE mark. The cobas pro integrated solutions is a scalable and modular diagnostic platform designed for high-volume laboratories.

NHS trusts need help to unlock full productivity potential

NHS trusts are determined to do everything they can to help health services to be even more productive but need support from government and national bodies to unlock their full potential for improvement, a new report from NHS Providers says.

Bio-Rad launches ddSEQ Single-Cell 3' RNA-Seq Kit for single-cell gene expression

Bio-Rad Laboratories has announced the launch of the ddSEQ Single-Cell 3' RNA-Seq Kit and complementary Omnition v1.1 analysis software for single-cell transcriptome and gene expression research.

Roche launches new highly-sensitive B-cell lymphoma test

Roche has announced the launch of the first clinically approved highly sensitive in situ hybridisation (ISH) test, the VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay, in countries accepting the CE Mark. The test is designed to help pathologists differentiate a B-cell malignancy from a normal, reactive response to an infection.

The Power to Disrupt - Clinical Diagnostics Expo UK – register now

Registration is open now for The Power to Disrupt - Clinical Diagnostics Expo UK, the ninth face-to-face event provided by Thornhill Healthcare Events in partnership with POCTInnovators.com. Taking place in London during September, Pathology in Practice will be supporting the event with a special supplement.

Beth Loudon joins BIVDA as Head of Market Access

BIVDA continues to strengthen its team, welcoming Beth Loudon as Head of Market Access from September 2024. Beth is currently the Medical and Surgical Consumables Director for NHS Supply Chain, leading the clinical and commercial team responsible for assurance of value and resilience for the supply of clinical goods to the NHS.

Cyber attack effects could last for months

The effects of the recent cyber attack on pathology services provider Synnovis could last for ‘months’ an NHS update has revealed. The clinical impact of the attack has seen a significant reduction in the number of tests which can be processed and reported back to clinical teams at Guy’s and St Thomas’ NHS Foundation Trust and King’s College Hospitals NHS Trust.

Roche receives FDA clearance on its digital pathology solution for diagnostic use

Roche has announced that its whole-slide imaging system, the Roche Digital Pathology Dx (VENTANA DP 200), has received 510(k) clearance from the US Food and Drug Administration (FDA). The system is intended to aid the pathologist in reviewing and interpreting digital images of scanned pathology slides, and assist diagnosis.

David Wells appointed as Science Council Chair

The Science Council has announced that David Wells CSci, Chief Executive of the Institute of Biomedical Science (IBMS), has been appointed as the new Chair of its Board of Trustees. David, who has been a trustee of the Science Council since 2022, will succeed Adam Donnan in September 2024.

Latest Issues

The Power to Disrupt - Clinical Diagnostics Expo UK

15 Hatfields
16 September, 2024

Microbe Conference 2024

Crowne Plaza Hotel, Sheffield, UK
20-22 September, 2024

Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time – Experiences and Opportunities

Hilton Glasgow, 1 William Street, Glasgow, Scotland, G3 8HT
26-27 September, 2024

The British Association for Cytopathology Annual Scientific Meeting

Aztec Hotel and Spa, Bristol, BS32 4TS
18 October, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024